Literature DB >> 11378048

Interstitial cystitis: a chronic visceral pain syndrome.

U Wesselmann1.   

Abstract

Interstitial cystitis (IC) has remained an unresolved problem in clinical urology. The etiology and pathophysiologic mechanisms of IC are still undetermined, and to date the diagnosis is based on the clinical characteristics of the disease and the exclusion of other diseases and pathology that can mimic the symptoms of IC. In clinical practice, much emphasis has been placed on finding a specific etiology and specific pathologic markers for the disease and on identifying specific events that precipitate IC; however, those have not been identified with certainty. In this review, an additional approach is proposed, taking into account the observation that IC shares many features with other chronic nonmalignant visceral pain syndromes. This approach is based on the conceptualization of 3 hypotheses: (1) a spectrum of different insults can lead to chronic visceral pain in patients with IC; (2) different underlying pathogenic pain mechanisms may require different pain treatment strategies for patients diagnosed with IC; and (3) multiple different pathogenic pain mechanisms may coexist in the same patient requiring several different pain treatment strategies (perhaps concomitantly) to successfully treat chronic visceral pain associated with IC. This concept is likely to lead to new insights into the pathophysiologic mechanisms of IC and to novel treatment avenues for patients with IC and-in a broader view-also for patients with other chronic visceral pain syndromes.

Entities:  

Mesh:

Year:  2001        PMID: 11378048     DOI: 10.1016/s0090-4295(01)01123-2

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  11 in total

Review 1.  Treatment of bladder pain syndrome and interstitial cystitis: a systematic review.

Authors:  Carolina Pazin; Andréia Moreira de Souza Mitidieri; Ana Paula Moreira Silva; Maria Beatriz Ferreira Gurian; Omero Benedicto Poli-Neto; Julio Cesar Rosa-E-Silva
Journal:  Int Urogynecol J       Date:  2015-08-14       Impact factor: 2.894

2.  Risk factors for painful bladder syndrome in women seeking gynecologic care.

Authors:  Colleen M Kennedy; Catherine S Bradley; Rudolph P Galask; Ingrid E Nygaard
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-07-02

3.  Etiology, pathogenesis, and diagnosis of interstitial cystitis.

Authors:  Grannum R Sant
Journal:  Rev Urol       Date:  2002

4.  Treatment of interstitial cystitis/painful bladder syndrome as a neuropathic pain condition.

Authors:  Lakshmi Vas; Manorama Pattanik; Vaishali Titarmore
Journal:  Indian J Urol       Date:  2014-07

Review 5.  Chronic prostatitis/chronic pelvic pain syndrome in elderly men: toward better understanding and treatment.

Authors:  Michel A Pontari
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

6.  Why are recurrent cervical cancers of the pelvic stump misdiagnosed as interstitial cystitis?: The urologist's point of view based on a case report.

Authors:  Jin Kyu Oh; Khae-Hawn Kim
Journal:  Can Urol Assoc J       Date:  2013 May-Jun       Impact factor: 1.862

7.  Clinical Remission Using Personalized Low-Dose Intravenous Infusions of N-acetylcysteine with Minimal Toxicities for Interstitial Cystitis/Bladder Pain Syndrome.

Authors:  Dipnarine Maharaj; Gayathri Srinivasan; Sarah Makepeace; Christopher J Hickey; Jacqueline Gouvea
Journal:  J Pers Med       Date:  2021-04-24

8.  Beta-adrenergic receptor activation in immortalized human urothelial cells stimulates inflammatory responses by PKA-independent mechanisms.

Authors:  Erin B Harmon; Jill M Porter; James E Porter
Journal:  Cell Commun Signal       Date:  2005-08-09       Impact factor: 5.712

Review 9.  Pathomechanism of Interstitial Cystitis/Bladder Pain Syndrome and Mapping the Heterogeneity of Disease.

Authors:  Jia-Fong Jhang; Hann-Chorng Kuo
Journal:  Int Neurourol J       Date:  2016-11-22       Impact factor: 2.835

10.  Interstitial cystitis antiproliferative factor (APF) as a cell-cycle modulator.

Authors:  Hani H Rashid; Jay E Reeder; Mary J O'Connell; Chen-Ou Zhang; Edward M Messing; Susan K Keay
Journal:  BMC Urol       Date:  2004-04-06       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.